RxDoctor Payments Data

Heather Wells, APRN

Family · Maysville, KYNPI 1629688973

Payments from drug & device makers

$1,707in general payments, 2019–2025

Across 115 payments — averaging $14.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$644
  • Corcept Therapeutics$131
  • Amgen$124
  • Exact Sciences$118
  • GSK$90
  • Lilly USA, LLC$61
  • plus $539 from 19 others

What the payments were for

  • Food & beverage$1,707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,707 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$940
Medicare patients
33
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol40$48,404
OzempicSemaglutide33$45,202
JardianceEmpagliflozin13$17,718
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$16,951
Repatha SureclickEvolocumab27$16,545
JanuviaSitagliptin Phosphate13$14,049
EliquisApixaban15$10,693
Fenofibrate35$8,167
Atrovent HfaIpratropium Bromide12$6,463
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$1,815
Albuterol Sulfate HfaAlbuterol Sulfate63$1,780
Duloxetine Hcl25$1,569
Omeprazole138$922
Gabapentin85$896
Buspirone Hcl74$870

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$48$48,40440 claims
Novo NordiskOzempic$44$45,20233 claims
GSKTrelegy Ellipta$90$16,95120 claims
PfizerEliquis$19$10,69315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.

Other family in Maysville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →